XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES              
Net loss $ (8,652,272) $ (6,918,320) $ (5,504,589) $ (5,681,742) $ (15,570,592) $ (11,186,331)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Depreciation and amortization         1,285,746 1,336,375  
Amortization of finance leases 12,810   13,159   24,043 23,652  
Amortization on discount associated with finance leases         16,445 212,649  
Amortization of debt discount and other debt-related items         910,992 479,065  
Accretion of reclamation liability         203,088 186,107  
Interest expense paid with common stock         240,066 107,507  
Research and development expense paid with common stock         1,208,180 0  
Gain on write-off of SSOF deposits         (400,000) 0  
Gain on sale of Facility 0   0   0 (178,193)  
Loss on extinguishment of debt 521,622   0   521,622 0  
Loss on conversion of debt 1,278,544   (32,800)   1,472,067 237,656  
Employee and director share based compensation         99,333 172,616  
Change in fair value of derivative instruments         833,614 (2,263,212)  
Change in fair value of investments         0 765,000  
Share of net loss of equity-method investments         1,225,185 806,264  
Other         302,167 (24,605)  
Changes in operating assets and liabilities:              
Prepaid expenses         (327,355) (79,391)  
Deposits - asset         0 289,485  
Other assets         222,123 78,976  
Accounts payable         1,301,050 213,124  
Accrued expenses, other liabilities and deposits         327,761 720,226  
Deferred gain         0 1,425,000  
Deferred revenue         23,673 0  
Other liabilities         249,998 0  
Net cash used in operating activities         (5,830,794) (6,678,030)  
CASH FLOWS FROM INVESTING ACTIVITIES:              
Purchase of mineral rights and properties, plant and equipment         (465,938) (816,071)  
Proceeds from sale of leased facility and related assets         0 21,000,000  
Purchase of Aqua Metals Transfer LLC and Facility         0 (12,000,000)  
Payments on contractual commitments associated with derivatives         (2,284,364) (3,500,000)  
Investment in SSOF         (530,000) 0  
Funding of reclamation bond         (50,000) 0  
Other         (68,000) (47,288)  
Net cash provided by (used in) investing activities         (4,663,938) 3,701,641  
CASH FLOWS FROM FINANCING ACTIVITIES:              
Principal payments on financing leases (25,065)   (25,066)   (50,131) (352,050)  
Proceeds from the issuance of common stock         5,213,710 2,650,000  
Principal payments of debt         (200,000) 0  
Issuances of debt         2,000,000 0  
Common stock issuance costs         (140,120) (257,620)  
Net cash provided by financing activities         6,823,459 2,040,330  
Net decrease in cash and cash equivalents         (3,671,273) (936,059)  
Cash and cash equivalents at beginning of period   $ 3,785,577   $ 2,521,772 3,785,577 2,521,772 $ 2,521,772
Cash and cash equivalents at end of period $ 114,304   $ 1,585,713   114,304 1,585,713 $ 3,785,577
NON-CASH INVESTING AND FINANCING ACTIVITIES:              
Issuance of common shares for debt conversion and accrued interest         (0) 121,193  
Issuance of common shares with debt         250,000 0  
Investment acquired with payable         1,285,961 0  
Issuance of common shares for due diligence and commitment fees         85,000 350,000  
Issuance of common stock in lieu of payment of marketing expense         162,693 0  
Fair value of common stock held by GenMat transferred to GenMat Advances (see Note 2)         694,970 0  
Return of common stock in connection with conversion of debt and accrued interest         0 (121,193)  
Investment shares received on sale of Facility         0 9,365,000  
Return of investment shares in lieu of escrowed funds         0 (1,500,000)  
Haywood Lease Amendment [Member]              
NON-CASH INVESTING AND FINANCING ACTIVITIES:              
Issuance of common stock for lease amendment         509,850 0  
AST Lease Amendment [Member]              
NON-CASH INVESTING AND FINANCING ACTIVITIES:              
Issuance of common stock for lease amendment         378,845 0  
Debt and Accrued Interest Converted Into Common Shares [Member]              
NON-CASH INVESTING AND FINANCING ACTIVITIES:              
Issuance of common shares for debt conversion and accrued interest         4,301,634 3,331,656  
Return of common stock in connection with conversion of debt and accrued interest         (4,301,634) (3,331,656)  
RenFuel Note Receivable [Member]              
CASH FLOWS FROM INVESTING ACTIVITIES:              
Funding of RenFuel note receivable         (1,030,000) 0  
Sierra Springs Opportunity Fund, Inc. (SSOF) [Member]              
CASH FLOWS FROM INVESTING ACTIVITIES:              
Advances to Affiliate         0 (935,000)  
GenMat [Member]              
CASH FLOWS FROM INVESTING ACTIVITIES:              
Advances to Affiliate         $ (235,636) $ 0